Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel in Arteriovenous Access Fistula Stenosis (PaciFIST-2)
NCT02040454Phase 2Withdrawn
- Sponsor
- Englewood Hospital
- Start
- Mar 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in arteriovenous fistula stenosis, sponsored by Englewood Hospital. Planned start Mar 2014; status: withdrawn.
02
Drugs
paclitaxel
03
Conditions
arteriovenous fistula stenosis
Beyond the preview
Go deeper on NCT02040454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040454.